Columbia Research Enhanced Value ETF
REVS
2 hedge funds and large institutions have $4.42M invested in Columbia Research Enhanced Value ETF in 2020 Q2 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 1 reducing their positions, and 0 closing their positions.
15% more capital invested
Capital invested by funds: $3.85M → $4.42M (+$565K)
0% more funds holding
Funds holding: 2 → 2 (0)
0.19% less ownership
Funds ownership: 98.34% → 98.15% (-0.19%)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
-$8.43K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Ameriprise
Minneapolis,
Minnesota
| $4.22M | – | – | – |
|
|
2
Jane Street
New York
| $195K | -$8.43K | -482 | -4% |
|
REVS Hedge Fund Activity: Q2 2020 in Review
2 of the 4,878 institutional investors tracked by Wall St. Rank reported a position in Columbia Research Enhanced Value ETF (REVS) for Q2 2020, worth a combined $4.42M — up 15% from $3.85M a quarter earlier.
Fund positioning in REVS was balanced in Q2 2020: 0 funds opened new positions, 0 closed out, 0 added to existing stakes and 1 trimmed.
The largest seller was Jane Street, cutting an estimated $8.43K.
- 2 institutional investors held Columbia Research Enhanced Value ETF (REVS) as of Q2 2020, unchanged from Q1 2020.
- Funds reported $4.42M of Columbia Research Enhanced Value ETF stock for Q2 2020, up 15% quarter-over-quarter.
- 0 funds opened new Columbia Research Enhanced Value ETF positions in Q2 2020 and 0 closed out.
- The largest Columbia Research Enhanced Value ETF seller in Q2 2020 was Jane Street, an estimated $8.43K sold.
Based on aggregated 13F filings for Q2 2020.